EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Axel Haverich
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haverich, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haverich, A.

Eur J Cardiothorac Surg 2004;26:S59-S61
© 2004 Elsevier Science NL

Review

Tissue engineering

Axel Haverich*

Department of Thoracic and Cardiovascular Surgery, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany

* Tel.: +49 511 5326580; fax: +49 511 5325404. (Email: haverich{at}thg.mh-hannover.de).

Tissue engineering concepts will enter the clinical arena in thoracic and cardiovascular surgery soon and at high speed, replacing many procedures currently in practice. Drivers for change are suboptimal implants (heart valves) and missing implants (heart muscle). Medical device industry has to include these new concepts into their future perspectives.

Key Words: Tissue engineering • Heart valves • Myocardial replacement • Autologous repair






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.